We’re always told information consolidation is for OUR safety
Los Angeles Times
Medicare and the Food and Drug Administration have announced a joint venture that promises to improve prescription drug safety and potentially reduce wasteful spending on medications.
The agencies said Thursday they have agreed on rules for using information from Medicare’s giant claims databases to create a computerized early warning network for problems with medications and medical devices that come to light after they go on the market.
Medicare will not turn over individual patient data to the FDA, but the two agencies’ computers will be able to “talk” to each other, to pose and answer questions that may reveal potentially risky side effects in new drugs. Since pre-market testing usually involves a limited number of patients, serious problems sometimes become evident only after hundreds of thousands of people begin using a product. More
Sphere: Related Content